Apollo Hospitals Navi Mumbai organised a Blood Cancer Survivor Support Group Meeting to emphasise the importance of early detection and evolving treatment strategies in haematological malignancies. The session brought together clinicians, patients, and survivors, thereby creating a platform for meaningful discussions on diagnosis, treatment, and long-term care.
Expert-Led Discussions on Diagnosis and Treatment Gaps
As per the press release, the session was led by Dr Punit Jain and Dr Vipin Khandelwal. Together, they addressed persistent gaps in early diagnosis and access to care. At the same time, they highlighted rapid advancements in next-generation therapies and underscored the growing need for structured survivorship care in both adult and paediatric patients.
Early Detection and Advanced Therapies Improve Outcomes
Dr Jain emphasised that delayed diagnosis remains a major challenge, as symptoms of blood cancers often mimic common illnesses. However, he noted that early detection can significantly improve survival outcomes. Furthermore, he pointed out that advancements in bone marrow transplant, CAR T-cell therapy, and immunotherapy are transforming treatment outcomes, even in complex and relapsed cases.
Shifting Focus Toward Survivorship and Quality of Life
In addition to treatment, the discussion focused on survivorship and post-treatment care. Dr Khandelwal stressed that survival alone is no longer sufficient; ensuring a good quality of life is equally critical. Therefore, he advocated for structured long-term follow-up, monitoring of late effects, and comprehensive psychosocial support for both patients and their families.
Case Studies Demonstrate Transformative Outcomes
To illustrate these advancements, the session featured compelling case studies that reflected the changing landscape of oncology.
In one case, a 54-year-old woman diagnosed with Philadelphia chromosome-negative B-cell Acute Lymphoblastic Leukaemia (B-ALL) experienced relapse during immunotherapy after presenting with severe infection. Despite multiple complications, clinicians adopted a stepwise treatment approach involving chemotherapy, immunotherapy, and CAR T-cell therapy. As a result, she achieved complete remission one year post-treatment and now maintains a good quality of life.
Advanced Therapies Offer Hope in Paediatric Relapse
Similarly, a 6-year-old child with Acute Lymphoblastic Leukemia (ALL) faced two relapses and a guarded prognosis. Following initial treatment elsewhere, the family sought advanced care at Apollo Hospitals Navi Mumbai during the second relapse. Despite severe complications, including infections and low immunity, the clinical team initiated salvage therapy with targeted treatment, followed by a haploidentical hematopoietic stem cell transplant using the father as a donor.
Importantly, the team pursued a curative approach rather than palliative care. Today, the child remains in complete remission for over 200 days, marking a significant milestone and demonstrating that even relapsed paediatric blood cancers can achieve curative outcomes with timely and advanced interventions.
Strengthening Awareness and Holistic Cancer Care
Through such initiatives, Apollo Hospitals Navi Mumbai aims to enhance awareness about early diagnosis while promoting a holistic approach to cancer care. Ultimately, the institution continues to advocate for models of care that extend beyond treatment to prioritise long-term well-being and quality of life for patients.